Federal Audit Exposes Millions in Questionable Medicare Billing for Vascular Surgeries

A recent report from the Department of Health and Human Services Office of the Inspector General reveals that approximately $105 million in Medicare payments were linked to potentially unnecessary vascular procedures performed in office settings. The federal audit identified roughly 140 physicians nationwide whose billing patterns raised significant red flags. Among this group, a subset of 26 doctors stood out for performing an unusually high volume of procedures, often treating significantly more patients than their peers while conducting double the average number of interventions per individual.

This investigation confirms long-standing concerns regarding the financial incentives introduced by the Centers for Medicare & Medicaid Services nearly two decades ago. While the agency originally aimed to reduce hospital costs by shifting common, minimally invasive vascular treatments to outpatient facilities, the policy inadvertently triggered a surge in procedures. Critics and medical experts argue that these financial structures have encouraged the overuse of invasive treatments, such as stent placements and plaque removal, even when patients suffer from only mild symptoms that do not require such aggressive intervention.

The consequences of this trend extend beyond taxpayer waste, as patients have reported severe complications, including amputations and fatalities, following procedures that may have been medically unwarranted. Although overall payments for these services have declined in recent years, the shift toward private office-based care continues to complicate oversight. By highlighting these specific billing anomalies, the inspector general’s findings underscore the urgent need for stricter regulatory scrutiny to protect patients from unnecessary risks and ensure that medical necessity remains the primary driver of clinical decision-making.